Skip to main content
Lima, Peru

6–10 October 2024

HIVR4P 2024, the 5th HIV Research for Prevention Conference

HIVR4P 2024

HIVR4P 2024, the 5th HIV Research for Prevention Conference, will take place in Lima, Peru, and virtually from 6 to 10 October 2024 and is expected to bring together around 1,500 participants.

The HIV Research for Prevention Conference is the only global scientific conference focused exclusively on the challenging and fast-growing field of HIV prevention research. This conference fosters interdisciplinary knowledge exchange on HIV vaccines, microbicides, PrEP, treatment as prevention and biomedical interventions, as well as their social and behavioural implications.

Join us for a virtual symposia series exploring the latest HIV prevention research in October 2023

You're invited to attend a series of three special virtual symposia in October 2023, bringing together the scientific community to address the biggest challenges in biomedical prevention.

Register now
alternative text

View the virtual symposia series programme

Implementation and rolling out of CAB-LA
Wednesday, 4 October, 12:00 – 13:00 Peru Time (PET) (19:00 – 20:00 CEST)  

  • Moderator: Mitchell Warren, AIDS Vaccine Advocacy Coalition (AVAC)
  • Presentation 1: CAB-LA for cis and trans women and men who have sex with men. Beatriz Grinsztejn, Fundação Oswaldo Cruz (Fiocruz)
  • Presentation 2: CAB-LA and vaginal ring scale up (civil society perspective). Imelda Mahaka, Pangaea Zimbabwe AIDS Trust (PZAT)
  • Live Q&A with the audience

Insights into HIV vaccine research
Wednesday, 11 October, 12:00 – 13:00 PET (19:00 – 20:00 CEST)  

  • Moderator: Susan Buchbinder, University of California
  • Presentation 1: Looking back on the Mosaico study. Jorge Sanchez, Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales, UNMSM
  • Presentation 2: Novel vaccine platforms. Devin Sok, International AIDS Vaccine Initiative (IAVI)
  • Live Q&A with the audience

The future of bNAbs
Monday, 16 October, 12:00 – 13:00 PET (19:00 – 20:00 CEST) 

  • Presentation 1: Requirements for bNAbs in HIV prevention. Florian Klein, University of Cologne
  • Presentation 2: Affordability and economic implications for bNAbs. Jayasree Iyer, Access to Medicine Foundation
  • Live Q&A with the audience